Catabasis Pharmaceuticals, Inc.
Q2 2019 13F Holders
Symbol
CATB
CUSIP
14875P206
Type
Equity
Class
COM NEW
Num filings
26
Total reported value, excl. options
$35.1 M
Compare 2019 Q2 to
2021 Q2
2021 Q1
2020 Q4
2020 Q3
2020 Q2
2020 Q1
2019 Q4
2019 Q3
2019 Q1
2018 Q4
Manager
Report Date
Value ($000)
Shares
Option Type